ACTAVIS TO EXPAND FLORIDA MANUFACTURING FACILITY

(The following is a reformatted version of a press release
issued by Florida Governor Rick Scott and received via e-mail.
The release was confirmed by the sender.) 
March 21, 2013 
Gov. Scott Announces Actavis to Expand Florida Manufacturing
Facility, Create 220 Jobs 
TALLAHASSEE, FL -  Today, Governor Rick Scott announced that
Actavis, Inc. (NYSE: ACT), a leading specialty pharmaceutical
company formerly known as Watson Pharmaceuticals, plans to
expand its pharmaceutical manufacturing and warehousing
facilities in Davie, resulting in the creation of 220 jobs. 
Gov. Scott said, “I welcome Actavis’ expansion and thank them
for choosing the Sunshine State. We are excited to see Actavis
create 220 new jobs for Florida families. Since December 2010,
Florida’s private-sector has created over 280,000 jobs and our
state’s unemployment rate is below the national average for the
first time in five years. There is no doubt that Florida is
moving in the right direction and the steps we are taking to
create an environment where our businesses can grow is working.” 
The expansion will involve the construction of a 30,000-square-foot addition comprising approximately 16,700 square feet of
pharmaceutical manufacturing space and 13,000 square feet of
warehouse space. 
To increase production, the company will invest about $40.5
million at the Davie site, which will include the construction
of the additional space as well as investment within its
existing facility.  Construction is slated to begin in the third
quarter of 2013, with completion anticipated in one year and
initiation of operations to follow. 
The Davie facility is Actavis’ center for excellence for the
manufacturing of immediate and extended release pharmaceuticals.
Organizations that assisted the company in facilitating its
expansion were Enterprise Florida Inc., Greater Fort Lauderdale
Alliance, State of Florida and the Town of Davie. 
“We are honored to have the support of the leaders of Town of
Davie, Enterprise Florida and Governor Rick Scott as we continue
to expand our presence in Florida.  Actavis is proud to support
Florida and [the] Town of Davie economy with skilled,
pharmaceutical industry jobs, and we are committed to expansion
of employment opportunities in the region,” said Paul Bisaro,
president and CEO of Actavis, Inc.  “In addition to Davie, we
also have packaging and distribution functions in Sunrise,
Florida and pharmaceutical research and development operations
in Weston, Florida.  Our Anda, Inc. division, the fourth largest
distributor of pharmaceuticals in the U.S. is also located in
Weston.  In total, Actavis employs approximately 1,400 people in
Florida.” 
The company’s growth is welcome news to its local community.
Town of Davie Mayor Judy Paul said, “We are very happy to have
Actavis in Davie and were very pleased to work with the company
in their expansion.  As one of Davie’s major employers, Actavis
has been a vital part of our community for many years.  This
expansion is very exciting and we wish them every future
success.” 
Bob Swindell, president and CEO of the Greater Fort Lauderdale
Alliance, shared Paul’s views from a county-wide perspective.
“Actavis is one of Broward County’s leading employers and their
expansion is a great indicator that our efforts to grow the
important and strong South Florida life sciences cluster
continues to pay off,” Swindell added. 
Actavis has been approved for nearly $2.9 million in grants, tax
refunds and employee training incentives (state and local) to
support its expansion. 
“Actavis’ choice to build its future in Broward County is a
winner for Florida.  It’s a testament to the strength of the
local and state business climate,” said Florida Secretary of
Commerce Gray Swoope.  “It’s also the outcome of a mutual vision
for economic growth by local, regional, business and government
partners.” 
The Actavis Davie manufacturing facility, in operation since
1992, comprises manufacturing, warehouse, quality, engineering
and shared services.  The site manufactures about 2.2 billion
units annually and is approved by the U.S. Food and Drug
Administration, Health Canada, and the European Medicines
Agency. 
### 
CONTACT:
GOVERNOR’S PRESS OFFICE
(850) 717-9282
media@eog.myflorida.com 
(sgp) NY 
#<278855.14078.3.4.1.0.76>#
 
 
Press spacebar to pause and continue. Press esc to stop.